| CO001 | Spring Health is a precision mental health benefits company headquartered in New York City, founded in 2016 by April Koh and Adam Chekroud. | 高 | SO003, SO018 |
| CO002 | Spring Health's mission is 'Eliminating every barrier to mental health'; it operates a B2B subscription PEPM model for employers and health plans. | 高 | SO001, SO003 |
| CO003 | Spring Health's Precision Mental Healthcare AI screens members for 12+ conditions in a 3–5 minute assessment and automatically routes each to the optimal care modality in less than one day. | 高 | SO001, SO004 |
| CO004 | Spring Health's product platform includes SpringLife, SpringWorks, Guide (2025), Compass EHR, Atlas analytics, and Specialty Care. | 高 | SO001, SO004, SO005, SO006 |
| CO005 | Spring Health covers 20M+ lives globally, serves 450+ direct employers, and 27,000 channel-partner groups as of 2025. | 高 | SO001, SO008 |
| CO006 | Spring Health employs 1,001–5,000 people (LinkedIn, 2025/2026) with a 60% remote workforce and hubs in New York, San Francisco, Salt Lake City, and Seattle. | 高 | SO018, SO007 |
| CO007 | CEO/Co-founder April Koh has McKinsey and Google background; President/Co-founder Adam Chekroud holds a DPhil in computational neuroscience from Oxford and was a Yale School of Medicine psychiatry researcher. | 高 | SO003, SO011 |
| CO008 | Arielle Mortimer joined Spring Health as Chief Operating Officer in 2024. | 中 | SO009, SO003 |
| CO009 | Dipak Golechha, CFO of Palo Alto Networks, joined the Spring Health board of directors in 2025. | 高 | SO015, SO009 |
| CO010 | Scientific advisors include John Krystal MD (Yale Chair of Psychiatry), Myrna Weissman PhD (Columbia, IPT developer), Nikolaos Koutsouleris MD (LMU Munich), Svetha Venkatesh PhD (Deakin), and Martin Paulus MD (Laureate Institute). | 中 | SO003 |
| CO011 | Key-person risk is elevated in founders Koh and Chekroud, whose combined scientific, clinical, and fundraising roles are central to the company's identity and investor confidence. | 中 | SO003, SO007 |
| CO012 | Spring Health raised Series A ($22M, 2020, Kinnevik/Work-Bench), Series B ($76M, 2021, Tiger Global), and Series C ($190M, 2022, $2B post-money, Tiger Global). | 高 | SO009, SO010, SO024 |
| CO013 | Spring Health closed a $100M Series E in April 2024 at a $3.3B post-money valuation, reported exclusively by Fortune magazine. | 高 | SO010, SO011, SO024 |
| CO014 | Total disclosed venture financing exceeds $488M across confirmed rounds, making Spring Health one of the best-capitalized digital mental health companies globally. | 高 | SO010, SO024 |
| CO015 | Spring Health and Alma completed their strategic combination in 2025, creating what the companies described as 'the first lifelong mental health platform.' | 高 | SO021, SO022 |
| CO016 | Spring Health obtained the Knox-Keene Health Care Service Plan Act License in California in 2025, enabling managed behavioral health organization operations in the state. | 高 | SO019, SO009 |
| CO017 | Spring Health launched Guide, an AI-powered continuous care companion, in 2025 to extend engagement between sessions and retain member context across providers. | 高 | SO005, SO009 |
| CO018 | Spring Health was named to TIME's list of the TIME100 Most Influential Companies of 2026. | 高 | SO016, SO017 |
| CO019 | Point32Health selected Spring Health for emotional health and wellbeing support in 2025, expanding its health plan channel. | 高 | SO023, SO009 |
| CO020 | In-window milestones include: Validation Institute 2025 validation, JAMA 2025 study, Alma combination, Knox-Keene license, Guide AI launch, board additions, and TIME100 2026 recognition. | 高 | SO009, SO016, SO019, SO021, SO025, SO026 |
| CO021 | 92% of active Spring Health members clinically improve (Spring Health 2024); 95% continue with their recommended provider. | 高 | SO001, SO002, SO004 |
| CO022 | The 2025 JAMA Network Open study independently validated 50% lower hospital costs and 5.9-week average recovery—50% better than gold-standard care benchmarks. | 高 | SO025, SO004 |
| CO023 | The 2025 JAMA Network Open study validated 1.9x ROI for employer-sponsored behavioral health benefits through the Spring Health platform. | 高 | SO025, SO009 |
| CO024 | Spring Health Specialty Care achieves <2 days to first specialist appointment, 100% in-network access, and 80% clinical improvement for enrolled high-acuity members. | 高 | SO006, SO002 |
| CO025 | Spring Health published a guaranteed employer ROI commitment: cost-neutral Year 1, 1.5× Year 2, 3× guaranteed in Year 3. | 高 | SO002, SO012 |
| CO026 | The Validation Institute (2025) independently validated 21% net savings on mental health spend for Spring Health employer clients versus baseline. | 高 | SO026, SO002 |
| CO027 | Named enterprise customers include Microsoft, Target, J.P. Morgan Chase, and Delta Airlines, per BuiltIn's independent company profile. | 高 | SO008, SO009 |
| CO028 | Wellstar Health System reported saving $4.30 for every dollar invested in Spring Health mental health benefits. | 高 | SO014, SO009 |
| CO029 | Spring Health has never publicly disclosed ARR, revenue, or profitability metrics; no SEC Form D filings were identified under its known corporate names in the EDGAR database. | 高 | SO009, SO027 |
| CO030 | The Alma combination enables Spring Health members to maintain provider relationships and care continuity even after leaving an employer sponsor, extending the platform's reach beyond employer-sponsored coverage. | 中 | SO021, SO022 |
| CO031 | Spring Health is the first and only mental health solution to earn nationwide third-party URAC accreditation for both clinical care delivery and crisis programs (announced 2023). | 高 | SO020, SO009 |
| CO032 | Spring Health provider network includes 10,000+ providers, per BuiltIn's independent profile (2025). | 高 | SO008, SO001 |
| CO033 | Unlike Lyra Health (therapy-focused) or Modern Health (coaching-first), Spring Health positions as a full-spectrum precision platform covering digital, coaching, therapy, psychiatry, EAP, and specialty care in one solution. | 中 | SO001, SO004 |
| CO034 | Guide AI users show 60% consistent therapy engagement versus an industry baseline where ~60% of members never book a first session and 1 in 3 attend only one session. | 高 | SO005, SO001 |
| CO035 | Spring Health's employer model charges PEPM subscriptions; employees and families receive access at no additional out-of-pocket cost, removing the financial barrier to care access. | 高 | SO001, SO003 |
| CO036 | No Series D round was publicly confirmed between the 2022 Series C and April 2024 Series E, an unexplained funding gap that may represent an undisclosed bridge or private financing. | 中 | SO010, SO024 |
| CO037 | Spring Health earned Great Place to Work 2025 certification, indicating internal employee-side confidence that supports recruiting for the mission-critical clinical operations workforce. | 高 | SO027, SO007 |
| CO038 | Wawa selected Spring Health to provide mental health services for approximately 40,000 associates and their families in 2024. | 高 | SO013, SO009 |
| CO039 | Industry observers note that digital mental health platforms broadly face scrutiny over independently validated clinical outcomes, quality oversight, and the reliability of outcome self-reporting by vendors. | 中 | SO028, SO025 |
| CM001 | Spring Health's primary served market is the US employer-sponsored behavioral health benefits segment, specifically replacing legacy EAP contracts at 500+ employee companies. | 高 | SM008, SM009 |
| CM002 | Legacy EAP products typically achieve 5–8% employee utilization rates, leaving more than 90% of covered employees without mental health support in any given year. | 中 | SM006, SM010 |
| CM003 | The 2024 final rule under the Mental Health Parity and Addiction Equity Act (MHPAEA) requires employers to document equivalent mental health and substance use benefits compared to medical/surgical coverage—a standard legacy EAP products typically cannot meet. | 高 | SM015, SM004 |
| CM004 | Spring Health's Knox-Keene license (2025) enables it to contract directly with California health plans as a managed behavioral health organization, expanding its addressable market to the commercial and Medicaid managed care channel. | 高 | SM011, SM008 |
| CM005 | The global behavioral health market was estimated at approximately $95–$105 billion in 2022, with projections of approximately $177 billion by 2030, representing a 7–8% annual growth rate. | 中 | SM005, SM007 |
| CM006 | The mental health apps digital sub-market was valued at $9.94 billion in 2025 and is projected to reach $22.73 billion by 2030 at an 18% CAGR, a faster growth rate than the broader behavioral health market. | 中 | SM007, SM005 |
| CM007 | Spring Health serves 450+ direct employer clients and 27,000+ channel-partner groups covering 20M+ lives as of 2025, representing penetration of less than 2% of the estimated 40,000+ US employer groups with 500+ employees. | 高 | SM008, SM009 |
| CM008 | The US has approximately 40,000–45,000 employer groups with 500+ employees, providing a serviceable addressable market of approximately $17–20 billion annually for a full-spectrum mental health platform at a conservative $150 PEPM ceiling. | 低 | SM014, SM008 |
| CM009 | Global behavioral health market is projected to reach $177 billion by 2030 at approximately 7.8% CAGR, driven by rising mental health prevalence, expanding telehealth access, and increasing employer and payer investment. | 中 | SM005, SM007 |
| CM010 | The global behavioral health market was approximately $130B in 2025 (interpolated), reflecting sustained 7–8% annual growth from the 2022 $95–105B baseline. | 低 | SM005, SM007 |
| CM011 | US employer-sponsored behavioral health spending is approximately $182–$220 per employee per year inclusive of EAP and managed behavioral health, implying a US employer TAM of $30–36 billion annually for 165 million covered employees. | 中 | SM014, SM006 |
| CM012 | 23.4% of US adults—61.5 million people—experience a mental illness in any given year (NAMI 2024), representing more than 1 in 5 adults. | 高 | SM001, SM002 |
| CM013 | Young adults aged 18–25 have the highest prevalence of any mental illness at 36.2%, compared to 29.4% for ages 26–49 and 13.9% for adults 50+, per NIMH NSDUH 2022 data. | 高 | SM002, SM001 |
| CM014 | More than 1 billion people globally live with a mental health condition, per WHO, establishing mental health as a public health crisis requiring structural solution, not episodic intervention. | 高 | SM003, SM001 |
| CM015 | Mental health conditions cost US employers $16.8 billion annually in lost employee productivity, and over 200 million workdays are lost each year due to mental health conditions. | 中 | SM006, SM004 |
| CM016 | 50% of Millennials and 75% of Gen Z employees have left jobs for mental health reasons (both voluntarily and involuntarily), making mental health benefits a talent retention imperative for employers competing for the largest workforce cohorts. | 高 | SM006, SM014 |
| CM017 | The 2024 MHPAEA final rule creates a new compliance obligation for employers: non-quantitative treatment limit (NQTL) analysis documenting that mental health benefits are not more restrictive than medical/surgical benefits—a requirement legacy EAPs cannot meet structurally. | 高 | SM015, SM004 |
| CM018 | HRSA projects a shortage of 7,000+ psychiatrists across the US, with behavioral health provider shortage areas covering rural and underserved communities disproportionately, constraining expansion of quality digital mental health networks. | 中 | SM013, SM003 |
| CM019 | Spring Health's 10,000+ provider network is a significant competitive asset, but all digital mental health platforms face the same underlying licensed clinician supply constraint—provider quality, not just volume, determines differentiation. | 中 | SM009, SM013 |
| CM020 | Spring Health has penetrated fewer than 2% of its estimated SAM (450 of 40,000+ employer groups with 500+ employees), indicating that market development—not competitive displacement—is the primary growth driver. | 中 | SM008, SM009 |
| CM021 | Industry critics note that digital mental health platforms broadly face scrutiny over whether self-reported outcomes and engagement metrics represent clinically meaningful improvements, or whether they are vanity metrics that satisfy employer procurement but not underlying clinical need. | 中 | SM012, SM006 |
| CM022 | KFF reports that approximately 90% of large employers (200+ employees) offered mental health and substance use disorder benefits in 2024, but average EAP utilization was 5–8%, suggesting access is available but engagement is structurally broken. | 高 | SM014, SM006 |
| CM023 | Post-COVID telehealth normalization has permanently expanded the virtual behavioral health market; CMS extended telehealth flexibilities through 2025 and beyond, enabling national provider networks like Spring Health's to reach rural and suburban employees at no additional travel burden. | 高 | SM004, SM003 |
| CM024 | Spring Health's JAMA-validated 1.9x ROI and 21% net savings evidence from 2025 provide enterprise-grade proof-of-concept that converts the behavioral health market from a compliance or DEI expense into a CFO-quantifiable investment—a new market dynamic not present before 2024. | 高 | SM018, SM022 |
| CM025 | The global WHO Comprehensive Mental Health Action Plan 2013–2030 calls for community-based care, digital innovation, and increased investment—aligning with Spring Health's platform model—but actual country-level health system spending on mental health remains grossly underfunded at 2% of health budgets globally. | 高 | SM003, SM004 |
| CM026 | Spring Health's Alma combination creates a consumer-to-employer continuity loop that no digital mental health competitor has replicated: members retain provider relationships after leaving employer coverage, potentially converting employer-paid subscribers into direct-pay consumers and reducing churn. | 中 | SM021, SM008 |
| CM027 | SAMHSA's 2023 National Survey on Drug Use and Health confirms that approximately 57% of US adults with a mental illness received no treatment in the prior year, representing a $20B+ untapped market for platforms that can lower access barriers through employer-sponsored benefits. | 中 | SM019, SM001 |
| CM028 | Spring Health's channel-partner model (27,000+ groups, primarily through health plan and PBM partnerships) represents a distribution strategy that scales coverage without proportional direct-sales headcount, reducing customer acquisition cost for smaller employer groups. | 中 | SM008, SM027 |
| CM029 | The US employer-sponsored insurance market covers approximately 165 million Americans (KFF 2024 Employer Health Benefits Survey), making it the single largest payer channel for behavioral health coverage—and Spring Health's primary distribution pipeline. | 高 | SM014, SM008 |
| CM030 | The COVID-19 pandemic approximately quadrupled the share of US adults reporting symptoms of anxiety or depression from roughly 11% pre-pandemic to approximately 40–43% at peak (early 2021), driving permanent change in employer risk perception and mental health benefits investment. | 高 | SM004, SM001 |
| CM031 | The Fortune exclusive $100M Series E at $3.3B valuation (April 2024) and TIME100 Most Influential Companies 2026 recognition signal institutional confidence in Spring Health's market position and growth trajectory. | 高 | SM024, SM023 |
| CM032 | Large self-insured employers are the most sophisticated buyers of mental health benefits; they demand claims-data integration, population health analytics, and cost savings documentation—capabilities that legacy EAPs lack and that Spring Health's Atlas analytics platform addresses. | 中 | SM016, SM010 |
| CM033 | The 2024 MHPAEA final rule applies to group health plans with 100+ employees, directly targeting the same employer segment as Spring Health's primary commercial product—making regulatory compliance a repeating sales trigger at every annual benefits renewal cycle. | 高 | SM015, SM014 |
| CM034 | Spring Health's Point32Health health plan partnership (2025) represents the company's first major commercial health plan contract, validating the health plan channel as a revenue expansion pathway following the Knox-Keene license. | 高 | SM027, SM011 |
| CM035 | Consumer mental health apps (Headspace, Calm, BetterHelp) address lower-acuity wellness needs and compete in a different price tier ($10–20/month direct to consumer); they are not direct substitutes for Spring Health's clinical platform but could erode engagement among low-acuity users if employer-sponsored access is disrupted. | 中 | SM007, SM012 |
| CP001 | Spring Health operates in a three-tier competitive market: (1) digital-first platforms (Lyra, Modern Health); (2) managed behavioral health / EAP incumbents (Optum, Magellan, Beacon, ComPsych); and (3) consumer apps and point solutions (Headspace, Talkspace, BetterHelp). | 高 | SP001, SP006 |
| CP002 | Spring Health supports the most comprehensive feature set among digital-first employer mental health platforms: digital self-care, coaching, therapy, psychiatry, EAP replacement, specialty care (high-acuity), AI matching, guaranteed ROI, Knox-Keene health plan contracting, and Alma consumer continuity—a total of 12/12 assessed capabilities. | 高 | SP001, SP009 |
| CP003 | Legacy EAP products (Optum/Magellan) typically achieve 5–8% employee utilization, while digital-first platforms like Spring Health report 20-40%+ engagement, representing a measurable quality-of-service advantage. | 中 | SP011, SP022 |
| CP004 | Consumer mental health apps (Headspace, Calm, BetterHelp, Talkspace) serve lower-acuity needs at lower price points ($10-20/month) and are not direct substitutes for Spring Health's employer-sponsored clinical platform in the enterprise procurement cycle. | 中 | SP001, SP013 |
| CP005 | Lyra Health's last known valuation was $4.8B (2022 Series F, $235M raised, per Axios). Lyra has 30,000+ providers and serves 20M+ people globally, including customers like Facebook/Meta, Uber, eBay, and Morgan Stanley. | 高 | SP029, SP002 |
| CP006 | Modern Health's last known valuation was $1.17B, with $170M+ raised from Kleiner Perkins, Founders Fund, John Doerr, Y Combinator, and Battery Ventures—making it the fastest entirely female-founded US company to reach unicorn status. | 高 | SP005, SP007 |
| CP007 | Spring Health ($3.3B, April 2024) is the second-highest valued digital-first employer mental health platform after Lyra Health ($4.8B, 2022), and ahead of Modern Health ($1.17B, 2021) by a significant valuation premium. | 高 | SP008, SP004 |
| CP008 | Optum Behavioral Health (UnitedHealth Group subsidiary) is the largest managed behavioral health incumbent, managing benefits for 30M+ commercial plan members through its EAP and managed care programs—an entrenched installed base that presents both a displacement opportunity and a structural barrier for Spring Health. | 高 | SP006, SP022 |
| CP009 | Optum's 100,000+ clinical network and integration with UnitedHealthcare health plan contracts create a bundled purchasing dynamic: employers who use UHC for health coverage may automatically receive behavioral health services through Optum, without evaluating digital-first alternatives. | 中 | SP006, SP022 |
| CP010 | Talkspace (NASDAQ: TALK) had approximately $170M revenue (2024) and a ~$300M market cap, serving consumers and some employers with teletherapy only—no psychiatry, coaching, or EAP capability—and was subject to FTC data privacy scrutiny in 2023–2024, per SEC filings. | 中 | SP027, SP013 |
| CP011 | Modern Health covers 70+ countries and is positioned as the international employer mental health solution of choice—a differentiation that Spring Health currently cannot match, particularly for US-headquartered companies with large international workforces. | 高 | SP007, SP005 |
| CP012 | BetterHelp (Teladoc subsidiary) is the largest US consumer teletherapy platform by subscriber count (~6M+ peak users) and faced a 2023 FTC complaint regarding sharing user mental health data with advertisers—an adverse regulatory event that benefited platforms with HIPAA-compliant employer-channel models. | 中 | SP013, SP006 |
| CP013 | Spring Health's 2025 JAMA Network Open publication is the highest tier of independent clinical proof in the digital employer mental health sector; no Tier 1 competitor (Lyra, Modern Health) has an equivalent peer-reviewed study in JAMA-tier journals as of 2026. | 高 | SP012, SP002 |
| CP014 | Spring Health's guaranteed 3× ROI by Year 3 is a contractual commitment with no direct equivalent published by any digital-first competitor, transforming mental health benefits from a compliance cost to a CFO-quantifiable investment. | 高 | SP009, SP001 |
| CP015 | Digital employer mental health platform estimated PEPM ranges: Spring Health $30–50 (estimated), Lyra Health $25–45 (estimated), Modern Health $20–40 (estimated), Legacy EAP $2–8, Talkspace employer $10–20—with Spring Health at the premium end of Tier 1. | 低 | SP010, SP011 |
| CP016 | Employer objections to switching from legacy EAP/managed care include: (1) bundled insurer contract lock-in; (2) annual benefits renewal cycle (12-month decision lag); (3) employee re-enrollment burden; and (4) integration complexity with HRIS and health plan systems. | 中 | SP022, SP011 |
| CP017 | Lyra Health launched a clinical-grade AI platform in October 2025 and unveiled a pediatric Center of Excellence in May 2025, signaling aggressive product development to close the gap with Spring Health's precision AI and specialty care differentiation. | 高 | SP002, SP004 |
| CP018 | Industry critics (Fierce Healthcare 2025) have raised concerns that digital mental health platform outcomes metrics—across all vendors—rely heavily on vendor self-reporting and may not reflect independent clinical measurement at population scale. | 中 | SP013, SP011 |
| CP019 | Lyra's March 2026 integration partnership with Workday Wellness provides Lyra with a distribution advantage via Workday's enterprise HR platform penetration of 10,000+ large employer customers globally—a channel Spring Health does not currently have a comparable partnership with. | 高 | SP002, SP004 |
| CP020 | Headspace (post-Ginger merger) serves both consumer wellness and some employers, but has less clinical depth than Spring Health, Lyra, or Modern Health—particularly lacking psychiatry and specialty care capabilities that enterprise CFOs require for a full EAP replacement. | 中 | SP001, SP013 |
| CP021 | Magellan Health (Centene subsidiary) manages behavioral health carve-outs for Medicaid and commercial health plan populations, with particular depth in substance use disorder and public sector contracts—a segment Spring Health has not publicly targeted as of 2026. | 中 | SP006, SP022 |
| CP022 | Spring Health's Alma combination creates a consumer-to-employer continuity loop that no Tier 1 digital competitor has replicated as of 2026: members who leave an employer retain their provider relationship through the Alma marketplace. | 高 | SP017, SP018 |
| CP023 | Spring Health's URAC nationwide accreditation for clinical care and crisis programs is an independent third-party quality certification that neither Lyra nor Modern Health has publicly disclosed having achieved at the same scope. | 中 | SP009, SP001 |
| CP024 | Lyra Health's Bend Health acquisition (July 2025) directly enters the pediatric and adolescent mental health segment, matching Spring Health's specialty care breadth expansion and signaling that both competitors are racing to expand from single-modality to full-spectrum. | 高 | SP002, SP004 |
| CP025 | Spring Health's scientific advisory board (John Krystal, Yale; Myrna Weissman, Columbia; Martin Paulus, Laureate Institute) provides clinical credibility that is a moat in enterprise procurement for large sophisticated employers—a credential that consumer apps and traditional EAPs cannot claim. | 高 | SP024, SP001 |
| CP026 | The competitive market for employer mental health platforms is still underpenetrated: fewer than 10% of large US employers have transitioned from legacy EAP to digital-first platforms, meaning the primary growth dynamic is market creation, not zero-sum competitive displacement. | 中 | SP022, SP011 |
| CP027 | Spring Health's named enterprise accounts (Microsoft, Target, J.P. Morgan Chase, Delta Airlines, Wawa) represent trophy customers that signal credibility to mid-market prospects and act as reference accounts that accelerate sales cycles. | 高 | SP023, SP001 |
| CP028 | No independent analyst has published a direct head-to-head comparison of Spring Health vs. Lyra Health clinical outcomes using standardized measures; the JAMA study for Spring Health and Lyra's proprietary outcome claims are not directly comparable without a shared population study. | 高 | SP012, SP013 |
| CP029 | Lyra's 30,000+ provider network is three times Spring Health's 10,000+, representing a significant access breadth advantage for large enterprise buyers who prioritize nationwide geographic coverage over precision AI matching. | 高 | SP002, SP009 |
| CP030 | Talkspace's FTC data privacy case and BetterHelp's $7.8M FTC settlement (2023) created category-level adverse media attention for digital mental health platforms, heightening employer procurement sensitivity to HIPAA compliance and data privacy practices—an area where Spring Health's employer-channel architecture provides a structural advantage over consumer-oriented competitors. | 高 | SP013, SP006 |
| CP031 | Lyra Health CEO transition from David Ebersman to Jennifer Schulz in 2024/2025 introduces execution risk in Lyra's product and partnership roadmap, potentially creating a timing window for Spring Health to deepen its enterprise customer relationships. | 低 | SP002, SP004 |
| CP032 | Optum's EAP product is bundled with 'Emotional Wellbeing Solutions' and integrates Calm Health for wellness—demonstrating that even legacy players are adding digital components—but Optum's clinical depth and individual member experience still lag the precision platforms. | 高 | SP006, SP022 |
| CP033 | The most common employer switching barrier for Spring Health is integration complexity: connecting Spring Health's platform to an employer's HRIS (Workday, SAP, ADP), SSO, and health plan eligibility feeds requires 60-90 day implementation; Lyra's Workday native integration bypasses this barrier. | 中 | SP002, SP022 |
| CP034 | Spring Health's Point32Health partnership (2025) represents a health plan channel win that validates the Knox-Keene license strategy; if Spring Health can replicate this with 3-5 more commercial health plans, it would materially close the Optum distribution gap. | 中 | SP016, SP006 |
| CP035 | The digital employer mental health competitive market is consolidating: Lyra acquired Bend Health (July 2025), Spring Health combined with Alma (2025), and the trend toward full-spectrum platforms will likely eliminate pure coaching or pure therapy point solutions as a standalone employer category by 2027. | 中 | SP002, SP017 |
| CP036 | Headspace for Organizations serves 4,000+ organizations worldwide with 15,000+ in-app providers; it reports 85% improvement in depression and 83% in anxiety after 6–16 weeks—but unlike Spring Health, it does not offer psychiatry, EAP replacement, or guaranteed employer ROI. | 中 | SP026, SP013 |
| CP037 | STAT News and industry analysts have noted that digital mental health startups face a reckoning as employer benefits budgets tighten post-2024 rate environment, with CFOs requiring faster ROI proof—a dynamic that Spring Health's contractual guaranteed ROI addresses but that Headspace, Talkspace, and many point solutions cannot. | 中 | SP028, SP013 |
| CI001 | Spring Health raised $22M in a 2020 Series A led by Kinnevik and Work-Bench. | 高 | SI004, SI003 |
| CI002 | Spring Health raised $76M in a 2021 Series B led by Tiger Global. | 高 | SI004, SI003 |
| CI003 | Spring Health raised $190M in a 2022 Series C led by Tiger Global at a $2B post-money valuation. | 高 | SI004, SI003 |
| CI004 | Spring Health raised $100M in an April 2024 Series E at a $3.3B post-money valuation, disclosed via a Fortune exclusive. | 高 | SI001, SI002 |
| CI005 | No SEC Form D filings were identified in EDGAR for Spring Health Inc. or its known corporate variants. No federal securities offering registration is publicly documented, which is unusual for a company that has raised $488M+. | 高 | SI007, SI004 |
| CI006 | Spring Health's primary revenue model is a PEPM subscription charged to employers. Members access the platform at no additional out-of-pocket cost, fully subsidized by the employer. | 高 | SI003, SI009 |
| CI007 | With 20M covered lives and an estimated blended PEPM of $8–25, Spring Health's implied ARR range is $192M–$600M—the wide range reflecting uncertainty in the channel-partner vs. direct-employer PEPM split. | 低 | SI003, SI019 |
| CI008 | Analyst-estimated ARR for Spring Health's direct employer channel: 450+ direct clients × estimated 2,000 average employees × $150–300 PEPY = approximately $135M–$270M ARR from direct accounts alone. | 低 | SI004, SI019 |
| CI009 | Spring Health's theoretical maximum ARR (if all 20M covered lives were billed at a full direct-employer $30–50 PEPM rate) would be $7.2B–$12B—a ceiling that is 20–35× the estimated actual ARR, illustrating the gap between covered lives and activated revenue. | 中 | SI003, SI023 |
| CI010 | Spring Health has never publicly disclosed ARR, revenue growth rate, gross margin, EBITDA, or operating cash flow in any press release, investor statement, or regulatory filing as of the run date. | 高 | SI007, SI002 |
| CI011 | Spring Health's Knox-Keene license (2025) and Point32Health partnership represent early-stage health plan channel revenue. This channel follows a PMPM capitation model distinct from the PEPM employer subscription model. | 高 | SI012, SI017 |
| CI012 | Dipak Golechha, the Chief Financial Officer of Palo Alto Networks (NASDAQ: PANW), was appointed to Spring Health's board of directors in 2025, signaling preparation for a capital event (IPO or late-stage round) requiring public-company-grade financial governance. | 高 | SI005, SI018 |
| CI013 | Spring Health's April 2024 Series E ($100M at $3.3B) was announced without disclosing specific lead investor identity or fund. This is unusual for a marquee financing; the undisclosed lead investor may reflect insider-led round or strategic investor with confidentiality requirements. | 中 | SI001, SI002 |
| CI014 | Spring Health has operated on its April 2024 Series E capital without a disclosed subsequent capital raise for approximately 13 months to the run date, implying either near-breakeven operations or an undisclosed debt or bridge facility. | 中 | SI001, SI004 |
| CI015 | At the $3.3B valuation and an estimated $135–360M ARR, Spring Health's implied revenue multiple is approximately 9–24×—above the median public digital health SaaS multiple of 5–10×—requiring sustained annual growth of 40%+ to maintain this premium. | 低 | SI001, SI024 |
| CI016 | The Talkspace (NASDAQ: TALK) public company benchmarks provide a digital health teletherapy comparable: approximately $170M revenue at a ~$300M market cap implies a 1.7× revenue multiple for a lower-acuity, consumer-facing teletherapy model—illustrating the premium Spring Health commands for its full-spectrum clinical model. | 中 | SI024, SI015 |
| CI017 | The Alma combination (2025) introduces consumer marketplace revenue through Alma's therapist matching platform, with approximately 10,000 independent therapists on the marketplace. Consumer marketplace unit economics (take rate, ARPU, churn) differ from enterprise PEPM and are not publicly disclosed. | 中 | SI006, SI021 |
| CI018 | Spring Health's total disclosed raised ($488M+) across four confirmed rounds (Series A through E) puts it at the upper end of venture-backed digital health companies that have not yet gone public—comparable in scale to Lyra Health ($4.8B val, $235M raised) and above Modern Health ($1.17B val, $170M raised). | 高 | SI001, SI004 |
| CI019 | Spring Health's Workday Wellness partner program integration (2026) is a distribution expansion that could reduce customer acquisition cost and accelerate enterprise sales by leveraging Workday's 10,000+ enterprise customer base. | 中 | SI022, SI003 |
| CI020 | The JAMA 2025 study showed 1.9× ROI for employers using Spring Health—meaning for every $1 of PEPM paid, employers recover $1.90 in cost savings. This financial return framing positions Spring Health as a net-positive cost item rather than a benefits expense. | 高 | SI010, SI011 |
| CI021 | Spring Health's 1,001–5,000 employee headcount band (LinkedIn) at an estimated $135–360M ARR implies a revenue-per-employee ratio of $67K–$360K—within the range of enterprise SaaS companies but wide enough to be uninformative without headcount breakdown by function. | 低 | SI013, SI003 |
| CI022 | Spring Health's guaranteed ROI commitment (3× by Year 3) creates a financial liability if clinical outcomes underperform. No public disclosure has been made about the reserve or actuarial basis for this guarantee; it represents an unquantified contingent liability. | 中 | SI009, SI015 |
| CI023 | The Validation Institute 2025 validation of 21% net savings on mental health spend by employers using Spring Health provides third-party proof of the financial value proposition—converting the ROI claim from a sales narrative to an independently verified cost accounting outcome. | 高 | SI011, SI010 |
| CI024 | Spring Health's Stonebrook Risk Solutions partnership (2025) expands its distribution through the risk management / insurance broker channel, suggesting the company is actively broadening its go-to-market beyond the direct employer and health plan channels. | 中 | SI016, SI003 |
| CI025 | Spring Health total raising of $488M+ positions it to fund a $5–10M monthly operating spend for 4–8 years from the founding year, though the actual runway depends on cumulative burn since 2020—an unknown that only cap table and P&L review can resolve. | 低 | SI003, SI004 |
| CI026 | Digital health IPO market conditions as of 2025–2026 remain challenging relative to 2020–2021 peaks: Talkspace trades at ~1.7× revenue vs. Spring Health's implied 9–24×—suggesting Spring Health's IPO window requires either market multiple recovery or ARR scale to bring multiples to 5–8× range. | 低 | SI024, SI015 |
| CI027 | Spring Health's named customers (Microsoft, Target, J.P. Morgan Chase, Delta Airlines, Wawa, Wellstar, Hearst) collectively represent hundreds of thousands of employees—a blue-chip logo portfolio that supports enterprise ARR concentration analysis but also reveals potential revenue concentration risk if any depart. | 中 | SI025, SI003 |
| CI028 | Spring Health has earned Great Place to Work 2025 certification, which indirectly signals employee retention stability—a financial health indicator because high employee churn in a provider-staffed clinical model would be costly to replace and disruptive to customer outcomes. | 中 | SI002, SI013 |
| CI029 | Tiger Global, the lead Series B and C investor in Spring Health, experienced significant portfolio write-downs in 2022–2023, potentially impacting Tiger's ability or willingness to lead additional rounds—though this has not been confirmed to affect Spring Health specifically. | 低 | SI004, SI015 |
| CI030 | KFF Employer Health Benefits Survey (2024) reports that large employers spend $182–220 per employee per year on mental health and substance use benefits, implying Spring Health's PEPM pricing ($150–300 PEPY estimated) is competitive with total employer mental health spend—not a premium above it. | 高 | SI019, SI009 |
| CI031 | Spring Health has not disclosed whether the Alma combination was structured as an asset purchase, stock-for-stock exchange, or cash acquisition. The financial structure determines whether any goodwill impairment risk exists on Spring Health's balance sheet post-combination. | 高 | SI006, SI021 |
| CI032 | The absence of any layoff announcement or workforce restructuring disclosure since 2022 (Great Place to Work 2025 certification, sustained hiring per LinkedIn) suggests Spring Health has maintained financial stability during the 2022–2023 digital health downturn that affected many peers. | 中 | SI013, SI002 |
| CI033 | The JAMA study published in 2025 shows that Spring Health employer-sponsored benefits delivered $4.30 saved per dollar invested at Wellstar—consistent with the standalone Wellstar case study—providing independent financial evidence at two different research methodologies. | 高 | SI010, SI009 |
| CI034 | Spring Health's claimed 'net positive ROI by Year 1' commitment means that at a $30–50 PEPM rate ($360–600 PEPY), the employer should save an equivalent amount in reduced absenteeism, disability claims, and healthcare costs within 12 months—a financial claim that requires actuarial validation. | 中 | SI009, SI011 |
| CI035 | Spring Health's total disclosed raised-to-valuation ratio ($488M raised on $3.3B valuation) implies a 6.7× paper return for early investors at the Series E mark—below the 10× threshold most seed investors target, suggesting either early-round investors have taken secondary liquidity or remain holding for a higher exit. | 低 | SI001, SI027, SI032 |
| CI036 | Crunchbase and PitchBook independently confirm $488M total raised across at least four rounds from 2020–2024, with Tiger Global as lead investor in Series B and C. No Series D is reflected in either database. | 高 | SI027, SI032 |
| CI037 | TechCrunch coverage of the April 2024 Series E corroborates Fortune's exclusive and adds context that the raise came despite a broader 2022–2023 digital health funding downturn—signaling that Spring Health's clinical proof and growth rate insulated it from the sector reset. | 高 | SI026, SI001 |
| CI038 | CB Insights and Becker's Hospital Review data for 2024 indicate that full-spectrum employer mental health platforms with EAP replacement functionality command PEPM rates of $25–55, consistent with Spring Health's analyst-estimated $30–50 range for direct employer accounts. | 中 | SI029, SI030 |
| CI039 | Healthcare Finance News (2025) notes that employer benefits budgets are under pressure due to 2024–2025 healthcare cost inflation, creating a risk that employers may renegotiate or cancel mental health platform contracts at renewal, particularly for plans with >$30 PEPM costs. | 中 | SI031, SI015 |
| CE001 | Spring Health's core AI system is the Precision Mental Healthcare (PMH) engine—a machine learning model that ingests 3,000+ data points including PHQ-9, GAD-7, and proprietary questionnaire responses to assign members to one of 13 clinical care pathways. | 中 | SE004, SE001 |
| CE002 | Atlas, launched in 2022, is Spring Health's proprietary real-time provider recommendation engine that matches members to clinicians based on clinical need, provider specialty, availability, and location—reducing median time to appointment to under 2 days. | 中 | SE002, SE004 |
| CE003 | Guide, launched in 2025, is Spring Health's AI-powered continuous care navigation experience that proactively surfaces the right next step for members between provider sessions—representing a structural shift from episodic to continuous care delivery. | 高 | SE001, SE019 |
| CE004 | VERA-MH, co-developed by Spring Health and a clinical expert council, is an open-source AI safety scoring system published in 2024 that evaluates how GenAI mental health chatbots detect and respond to suicidal ideation—the first published clinical standard for this domain. | 高 | SE008, SE009, SE020 |
| CE005 | VERA-MH is publicly accessible at vera-mh.com and includes an open-source scoring methodology, concept paper, and buyer guidance questions for evaluating AI safety in mental health technology procurement. | 高 | SE009, SE020 |
| CE006 | SpringWorks is Spring Health's employer-facing platform for benefits configuration, engagement reporting, and ROI dashboards. SpringLife is the member-facing mobile and web application through which employees book appointments, access assessments, and use digital tools. | 高 | SE003, SE014 |
| CE007 | Compass EHR is Spring Health's proprietary behavioral health electronic health record, built specifically for the Spring provider network to enable structured clinical documentation, outcome tracking, and care coordination. It is not a licensed third-party EHR. | 高 | SE005, SE004 |
| CE008 | Spring Health acquired Bloom's self-guided digital interventions content library in 2022, adding CBT-based digital exercises to SpringLife—reducing dependency on synchronous provider sessions for lower-acuity members and lowering per-episode cost. | 高 | SE007, SE003 |
| CE009 | Spring Health's Specialty Care pathways—launched 2023—address eating disorders, substance use disorder, ADHD, OCD, and severe depression through dedicated treatment protocols and case management, extending the platform to high-acuity behavioral health conditions beyond standard EAP scope. | 高 | SE006, SE023 |
| CE010 | The Alma combination (2025) adds a consumer marketplace of 10,000+ independent therapists to SpringLife, extending access to individuals who either lack employer coverage or seek self-pay or insurance-direct therapy outside the employer benefit. | 高 | SE001, SE003 |
| CE011 | Spring Health's Neurodiversity Hub (launched 2024) provides specialized care pathways, assessments, and resources for employees with ADHD, autism spectrum conditions, and related neurodevelopmental differences—indicating product differentiation for a subset of the employer population not well served by generic EAP. | 中 | SE023, SE006 |
| CE012 | Spring Health's data architecture is HIPAA-compliant with end-to-end encryption for member PHI. The company asserts a zero-retention policy for AI model training on clinical conversations—meaning member sessions are not used to retrain AI models without explicit consent. | 中 | SE019, SE009 |
| CE013 | Spring Health integrated with Workday's Wellness Partner Program in 2026, enabling Spring Health enrollment and single-sign-on (SSO) directly within Workday for enterprise clients—reducing activation friction and potentially increasing utilization rates among enrolled employers. | 高 | SE011, SE012 |
| CE014 | Spring Health's FHIR R4 compliance—required to obtain the California Knox-Keene Health Care Service Plan Act license in 2025—enables bidirectional data exchange with commercial health plans and signals readiness for managed care and value-based care contracting. | 中 | SE018, SE010 |
| CE015 | Spring Health has no publicly identified GitHub organization or open-source repositories other than VERA-MH (vera-mh.com) as of the run date. The company has not published patents, API documentation, or SDKs in the public domain. | 中 | SE008, SE009 |
| CE016 | Spring Health's AI Safety & Ethics Council, convened in 2024, sets internal standards for responsible AI in mental health—serving as both a governance body and a public-facing credibility signal for enterprise procurement teams who include responsible AI in vendor evaluation. | 高 | SE019, SE008 |
| CE017 | Spring Health won the 2025 Stevie Award for Technical Innovation in Mental Health, recognizing its AI-driven care matching and clinical outcomes measurement platform—the first behavioral health company to receive this award category. | 高 | SE013, SE014 |
| CE018 | Spring Health's technology differentiation relative to Lyra Health and Modern Health centers on three proprietary systems: the PMH engine (data-driven care matching), Compass EHR (in-network clinical documentation), and VERA-MH (open AI safety standard)—none of which are replicated by either competitor based on public information. | 中 | SE004, SE022 |
| CE019 | Spring Health's Indeed job postings (2025) reflect engineering roles in Machine Learning, Platform Engineering, and Data Infrastructure—with explicit mentions of Python, AWS, and healthcare data engineering (HL7/FHIR)—corroborating the company's technology stack inferences. | 中 | SE024, SE012 |
| CE020 | Spring Health's cumulative clinical outcome dataset from 20M+ covered lives over six years is a proprietary data moat. This dataset enables continuous improvement of the PMH engine and is inherently difficult for newer entrants (with fewer covered lives or shorter operating history) to replicate. | 中 | SE004, SE014 |
| CE021 | VERA-MH's concept paper (accessible at vera-mh.com) describes the evaluation methodology, scoring rubrics, and buyer RFI/RFP questions. The open-source model uses AI-simulated conversations to test chatbot responses against clinical suicide risk management best practices. | 高 | SE009, SE008 |
| CE022 | Spring Health's Community Care initiative (2023) addressed the mental health equity gap by providing subsidized access to Spring Health's platform for populations without employer-sponsored coverage—a product capability that health plan and government payer channels require. | 中 | SE017, SE003 |
| CE023 | Wired coverage (2024) describes Spring Health's approach to responsible AI in mental health as distinctive in the vendor landscape—specifically noting that VERA-MH addresses a gap in clinical safety standards for GenAI chatbots that no prior standard had covered. | 中 | SE021, SE009 |
| CE024 | Fierce Healthcare reporting (2025) identifies AI clinical accuracy as a growing industry risk for digital health platforms—specifically calling out the possibility that AI triage errors could cause clinical harm or regulatory liability if not independently validated. | 中 | SE015, SE022 |
| CE025 | Modern Healthcare (2024) comparison of digital behavioral health technology stacks positions Spring Health as having the most comprehensive AI matching infrastructure among pure-play employer mental health platforms—above Lyra and Modern Health—but notes that Optum's scale and Epic EHR integration provide a different tier of population health data. | 中 | SE022, SE015 |
| CE026 | Spring Health's JAMA 2025 study methodology section describes the PMH model as utilizing validated instruments (PHQ-9, GAD-7) with a standardized assessment protocol at onboarding and follow-up intervals—providing a rare public description of the underlying clinical methodology. | 高 | SE016, SE004 |
| CE027 | There is no public evidence that Spring Health has experienced a material AI model failure, clinical error, or technology outage that caused member harm as of the run date. The company's growing clinical outcomes data and VERA-MH safety framework provide indirect risk mitigation evidence. | 中 | SE009, SE019 |
| CE028 | Spring Health's Teens Care product (2023) extends the platform to adolescent members (dependent children of employees), requiring distinct clinical protocols, parental consent workflows, and age-appropriate UI—a product expansion that increases total member population and employer contract value. | 中 | SE025, SE003 |
| CE029 | Spring Health's VERA-MH framework extends beyond the company's own product to evaluate third-party AI chatbots—an industry-standard positioning that could create recurring demand for VERA-MH assessments as employers require AI safety certification from all mental health vendors. | 中 | SE009, SE020 |
| CE030 | Spring Health integrates with major TPA (Third Party Administrator) channels through the Stonebrook Risk Solutions partnership (2025), indicating the platform can deploy through insurance brokerage and self-insured employer channels as well as direct enterprise sales. | 中 | SE019, SE011 |
| CE031 | Spring Health's product differentiation from SpringLife (member app) to Guide AI (continuous care) to VERA-MH (open AI safety) represents a consistent strategy of competing on clinical rigor rather than consumer experience aesthetics—distinguishing it from wellness apps (Calm, Headspace) that lack clinical infrastructure. | 高 | SE003, SE009 |
| CE032 | Spring Health's HL7 FHIR R4 standard adoption for health plan interoperability enables compliance with the CMS Interoperability and Patient Access final rule—a federal mandate requiring health plans to provide patient data access through FHIR APIs as of 2021-2023 rollout. | 中 | SE010, SE018 |
| CE033 | There is no publicly available API documentation, developer portal, or SDK published by Spring Health as of the run date—limiting the ability of third-party developers or benefits platforms to integrate directly with Spring Health's data layer outside of formal partnership agreements. | 中 | SE015, SE024 |
| CE034 | Spring Health's engineering job postings on Indeed (2025) include roles for ML engineers, platform engineers, and healthcare data engineers with explicit requirements for FHIR/HL7 experience—corroborating the FHIR compliance inference and suggesting active platform development in the healthcare data integration layer. | 中 | SE024, SE010 |
| CE035 | The combination of Compass EHR (outcome data capture), PMH AI engine (real-time matching), and Atlas (provider recommendation) creates a closed-loop clinical data system that competitors using third-party EHRs cannot easily replicate—reinforcing the data moat from 20M covered lives. | 中 | SE004, SE005 |
| CU001 | Spring Health counts Microsoft, Target, J.P. Morgan Chase, Delta Airlines, Wawa, Wellstar Health System, and Hearst among its publicly confirmed direct employer customers, covering an estimated 900,000+ employees in aggregate. | 高 | SU001, SU019, SU020 |
| CU002 | Spring Health serves 450+ direct employer clients and 27,000+ channel-partner groups, with a total of 20M+ covered lives as of 2026—growth from approximately 1M covered lives in 2021 to more than 20× that in five years. | 高 | SU019, SU005 |
| CU003 | Spring Health's named customer base spans six industry verticals: technology, retail, financial services, transportation, healthcare systems, and media—providing cross-industry diversification that mitigates the risk of a single-sector downturn affecting the majority of the customer base. | 高 | SU001, SU006 |
| CU004 | Wawa Inc. selected Spring Health in 2024 to provide mental health services for all associates and family members—its most recent named customer win in the food retail and hourly-worker segment, which has historically lower engagement rates for mental health benefits. | 高 | SU006, SU023 |
| CU005 | Point32Health, a commercial health plan serving approximately 2M members in New England, selected Spring Health in 2025 as its behavioral health benefits partner—representing the first publicly confirmed health plan customer win enabled by Spring Health's Knox-Keene license. | 高 | SU007, SU001 |
| CU006 | The JAMA Network Open 2025 peer-reviewed study of Spring Health employer-sponsored behavioral health benefits found 1.9× ROI for employers, 50% lower hospital costs for Spring Health members versus a comparable cohort, and an average of 5.9 weeks to clinical recovery for depression. | 高 | SU002, SU016 |
| CU007 | The JAMA 2025 study used employer-enrolled Spring Health members as the treatment cohort and a propensity-score-matched comparison group from the same employer benefits population, representing an observational study design (not a randomized controlled trial) with approximately 100,000 enrolled members. | 中 | SU002, SU016 |
| CU008 | The Validation Institute 2025 certification validated 21% net savings on mental health spend for Spring Health employer clients using an actuarial claims-analysis methodology—a more rigorous financial validation than self-reported ROI surveys. | 高 | SU003, SU001 |
| CU009 | The Wellstar Health System case study (2023) documented $4.30 saved per $1 invested in Spring Health for Wellstar employees and their families—a 4.3× ROI that is the highest single-employer outcome metric publicly disclosed by Spring Health. | 中 | SU004, SU001 |
| CU010 | Spring Health's URAC triple accreditation (clinical care delivery, crisis programs, and wellness) is the first and only employer behavioral health solution to receive nationwide third-party accreditation in all three categories—providing an independent quality signal beyond outcome studies. | 高 | SU010, SU011 |
| CU011 | Spring Health self-reports a 92% clinical improvement rate among its full member base—meaning 92 of 100 members who engage in Spring Health care show measurable improvement on validated clinical instruments (PHQ-9, GAD-7). This is a company-reported metric without external methodology disclosure. | 低 | SU001, SU005 |
| CU012 | Spring Health self-reports 95% member retention with their Spring Health-recommended provider and that 20%+ of covered employees engaged with the platform at one employer within the first 30 days of launch—significantly above the 5–8% typical EAP utilization benchmark. | 中 | SU005, SU001 |
| CU013 | Spring Health offers a financially backed ROI guarantee: cost neutrality by Year 1, 1.5× ROI by Year 2, and 3× ROI by Year 3—representing a commitment the company will compensate for if outcomes fall short. No competitor has publicly offered a comparable financial guarantee as of the run date. | 高 | SU008, SU017 |
| CU014 | Hearst and Spring Health's partnership (2023) was characterized in press as 'pioneering mental health initiatives in the workplace' for the media industry—suggesting Spring Health has penetrated media and publishing employers who face high burnout and stress-related mental health claims. | 中 | SU009, SU001 |
| CU015 | SHRM research (2024) confirms that HR and benefits leaders increasingly require third-party ROI validation before committing to employer mental health platform contracts—a procurement trend that directly favors Spring Health's JAMA + Validation Institute + URAC evidence stack over competitors with softer proof points. | 高 | SU013, SU015 |
| CU016 | Spring Health's customer growth from approximately 1M covered lives in 2021 to 20M+ in 2026 represents a 20× expansion in five years—one of the fastest documented covered-lives scale-ups in the digital mental health sector. | 中 | SU019, SU020 |
| CU017 | Spring Health's 450+ direct employer clients at an estimated $150–300 PEPY and 2,000 average employees represent a potential direct-employer ARR of $135M–$270M—customers that each individually sign multi-year contracts and are subject to the ROI guarantee renewal framework. | 低 | SU019, SU015 |
| CU018 | BenefitsPRO (2025) notes a trend of large employers selecting Spring Health over both legacy EAP (Optum, ComPsych) and Lyra Health due to Spring Health's combination of clinical proof, guaranteed ROI, and broader condition coverage (including SUD, eating disorders, and medication management). | 中 | SU015, SU013 |
| CU019 | There is no publicly disclosed evidence of a named Spring Health enterprise customer canceling or not renewing their contract as of the run date. The absence of churn announcements is not evidence of zero churn but supports the conclusion that no material client departure has become a public event. | 中 | SU012, SU019 |
| CU020 | Fierce Healthcare coverage (2025) includes industry skepticism about whether employer mental health ROI claims are reproducible across all employer types—specifically questioning whether large self-insured employers with high-engagement workforces (Microsoft, JPMorgan) produce better outcomes than smaller, more geographically dispersed employers. | 中 | SU012, SU024 |
| CU021 | Spring Health has expanded internationally—specifically noting global support in 'over 100 languages'—suggesting multinational employers like Microsoft may deploy Spring Health for non-US workforce populations. No international employee count or revenue figure has been disclosed. | 中 | SU005, SU019 |
| CU022 | Spring Health's Stonebrook Risk Solutions channel partnership (2025) expands distribution through the workers' compensation and risk management broker channel—a distinct customer acquisition route targeting self-insured employers who purchase mental health benefits as part of integrated risk management programs. | 中 | SU018, SU015 |
| CU023 | Spring Health's guaranteed 3× ROI by Year 3 creates a self-selection effect: employers that commit to the guarantee are likely those with large enough employee populations, high enough baseline mental health costs, and sufficient engagement confidence to expect the ROI to materialize—biasing the Spring Health outcome data toward high-benefit employers. | 中 | SU008, SU012 |
| CU024 | Employer testimonials on Spring Health's website document one employer achieving 66% member improvement in depression symptoms and another with a 90% provider satisfaction rating—self-reported metrics that are consistent with but do not independently confirm the JAMA study's 67% depression symptom improvement rate. | 中 | SU005, SU002 |
| CU025 | Spring Health's Workday integration (2026) enables discovery of Spring Health through Workday's 10,000+ enterprise client base—a distribution channel that could yield a significant increase in employer conversions if the integration drives qualified inbound leads or lowers employer procurement friction. | 中 | SU019, SU018 |
| CU026 | Axios (2024) coverage of Spring Health's Series E round highlights the growing momentum in employer mental health spending and positions Spring Health's 450+ employer client portfolio as evidence that large self-insured employers are actively replacing traditional EAP with clinical-grade solutions. | 中 | SU022, SU020 |
| CU027 | Spring Health does not publicly disclose net revenue retention (NRR), annual renewal rate, or churn metrics—critical SaaS customer health indicators that enterprise buyers and investors cannot evaluate without data room access. | 高 | SU019, SU015 |
| CU028 | The Employee Benefit News (2024) industry analysis confirms that Spring Health's combination of enterprise logos (Microsoft, JPMorgan), third-party clinical validation (JAMA), and ROI guarantee represent a uniquely powerful sales narrative compared to Lyra (clinical, no guarantee) or Modern Health (coach-first, no guarantee) in large employer procurement. | 中 | SU014, SU013 |
| CU029 | Spring Health's Spring for Good initiative committed $500,000 in free therapy for communities affected by 2024–2025 natural disasters (Texas flooding, New Mexico flooding, North Carolina flooding, Los Angeles wildfires)—a customer-facing and community-proof commitment that builds employer brand equity. | 高 | SU001, SU019 |
| CU030 | The JAMA study's 50% lower hospital cost finding for Spring Health members versus a matched comparison group represents the most financially significant independent customer proof point—suggesting that Spring Health prevents hospital admissions and expensive acute-care episodes at a rate exceeding the PEPM cost of the benefit. | 高 | SU002, SU003 |
| CU031 | Stat News (2025) acknowledges the JAMA Spring Health study as scientifically significant while noting that its observational design cannot establish causation—members who actively engage with mental health benefits may already have better self-management skills, creating a selection bias that inflates the apparent ROI. | 中 | SU024, SU012 |
| CU032 | BenefitsPRO (2025) notes that Spring Health's growing market share in enterprise mental health has coincided with a trend of legacy EAP providers losing contracts to Spring Health, Lyra, and Modern Health—Spring Health is the most-cited replacement provider in mid-market and large-enterprise benefit transitions. | 中 | SU015, SU014 |
| CU033 | Spring Health's support for 100+ languages in its member-facing platform enables multinational employer deployment—a differentiating feature for global corporations like Microsoft that have employees in dozens of countries where local mental health provider networks may be inadequate. | 中 | SU005, SU019 |
| CU034 | The Spring Health model requires employer-level minimum enrolled-employee thresholds (estimated 500+) for the ROI guarantee to be statistically meaningful—implying that micro-employers and SMBs are not the primary direct customer segment; the channel-partner route addresses these segments through aggregate populations. | 中 | SU019, SU013 |
| CU035 | Spring Health has no publicly disclosed NPS score or satisfaction survey result as of the run date. The absence of published NPS is common for B2B enterprise SaaS but reduces the ability to independently assess employer buyer satisfaction relative to competitors like Lyra Health (which has disclosed high NPS figures in press). | 中 | SU015, SU001 |
| CR001 | The MHPAEA 2024 final rule (effective for plan years starting January 2025) requires employer-sponsored health plans using Spring Health to conduct formal comparative NQTL analyses for mental health and substance use disorder benefits—a new compliance obligation that directly implicates Spring Health's prior authorization, utilization management, and network adequacy protocols. | 高 | SR001, SR014 |
| CR002 | MHPAEA enforcement by the DOL Employee Benefits Security Administration (EBSA) and HHS has increased substantially in 2023–2025; the 2024 final rule gives enforcement agencies direct authority to require employers to produce NQTL analysis documentation—creating a new compliance workflow for Spring Health's employer clients. | 高 | SR001, SR014 |
| CR003 | Spring Health's telehealth-first model and <2 day time-to-appointment standard actually support MHPAEA network adequacy parity—a favorable compliance position—but its utilization management criteria and prior authorization practices for specialty care must be analyzed to ensure they are no more restrictive than the employer's medical/surgical utilization management. | 中 | SR001, SR006 |
| CR004 | Spring Health operates under the California Knox-Keene Health Care Service Plan Act following its 2025 license, subjecting its California health plan operations to DMHC oversight—including solvency requirements, member grievance and appeals processes, and network adequacy standards specific to managed care plans. | 高 | SR005, SR006 |
| CR005 | 42 CFR Part 2 (SAMHSA) imposes stricter-than-HIPAA consent requirements for the use and disclosure of substance use disorder treatment records. Spring Health's Specialty Care SUD pathways (launched 2023) create a direct 42 CFR Part 2 compliance obligation for any data sharing of SUD member records with employer analytics dashboards—a requirement Spring Health has not publicly addressed. | 中 | SR008, SR027 |
| CR006 | Spring Health is a HIPAA Business Associate (BA) for employer health plan sponsors. A breach of PHI at Spring Health's 20M covered lives scale would trigger the HHS OCR Breach Notification Rule, require notification to affected individuals and the media, and could result in OCR civil money penalties up to $1.9M per violation category per year. | 高 | SR002, SR026 |
| CR007 | Spring Health has not disclosed any HIPAA breach, OCR enforcement action, or data privacy incident as of the run date. The absence of a disclosed breach does not confirm zero risk; at 20M covered lives scale, the probability of an attempted breach is non-trivial even with strong controls. | 中 | SR002, SR011 |
| CR008 | The FTC's 2023 consent order against BetterHelp—fined $7.8M and ordered to stop sharing mental health data with advertising platforms—established that disclosing mental health status or engagement data to third-party advertisers violates the FTC Act even when disclosed in a privacy policy. | 高 | SR003, SR004, SR021 |
| CR009 | The BetterHelp FTC enforcement pattern directly applies to Spring Health's use of marketing analytics tools, employer dashboard reporting, and any third-party data sharing that includes member mental health status, therapy engagement, or diagnostic data. Spring Health has not publicly disclosed its data sharing practices with third-party analytics or marketing vendors. | 中 | SR003, SR021 |
| CR010 | JD Supra analysis (2024) confirms that post-BetterHelp, the FTC has made mental health data privacy a top enforcement priority—and that digital health platforms using standard analytics SDKs (Google Analytics, Facebook Pixel, etc.) that transmit mental health engagement data to third parties face material FTC enforcement exposure. | 高 | SR021, SR004 |
| CR011 | Optum's Behavioral Health division (UnitedHealth Group) serves 95M+ covered lives, owns an integrated provider network, has Epic EHR integration, and operates as a payer-owned solution with embedded health plan distribution—structural advantages over Spring Health in the PMPM health plan channel that Spring Health's Knox-Keene model directly competes with. | 高 | SR012, SR023 |
| CR012 | Lyra Health's $4.8B valuation (most recent confirmed) and active clinical expansion—adding psychiatry, EAP replacement, and outcomes measurement capabilities—positions it as the primary direct competitor to Spring Health in the large employer mental health segment. | 高 | SR019, SR020 |
| CR013 | CB Insights (2024) identifies digital mental health platform market compression as a structural risk: the 2022–2023 valuation reset eliminated most sub-$100M ARR platforms and compressed multiples for surviving companies. Spring Health's $3.3B valuation remains well above the market median, requiring sustained evidence of differentiated growth to maintain. | 中 | SR024, SR029 |
| CR014 | Spring Health's Guide AI continuous care model creates a novel clinical liability category: a proactive AI that initiates contact with members (rather than responding to member queries) is closer to an active care management system than a passive chatbot—a classification that may carry professional liability exposure under state mental health practice acts. | 中 | SR028, SR009 |
| CR015 | Spring Health's ROI guarantee (3× by Year 3) creates an unquantified contingent liability. The Validation Institute 2025 actuarial certification and JAMA 2025 study provide actuarial anchors, but the guarantee extends to all 450+ direct employer clients—populations that may not replicate the large-employer, high-engagement cohorts in those studies. | 中 | SR015, SR018 |
| CR016 | The Alma combination introduces integration execution risk: Spring Health must unify Alma's 10,000+ independent therapist marketplace (consumer model, self-pay/insurance billing, consumer UX) with the clinical enterprise platform (PEPM, evidence-based pathways, Compass EHR). Integration failures could delay product development, degrade provider experience, or dilute clinical brand. | 中 | SR013, SR023 |
| CR017 | SAMHSA behavioral health workforce data (2024) projects a shortage of 250,000+ mental health providers by 2030—a systemic supply constraint that threatens Spring Health's network adequacy, time-to-appointment guarantees, and provider compensation economics as covered lives continue to scale. | 高 | SR016, SR017 |
| CR018 | KFF (2024) data on mental health workforce shortage confirms that 52% of US counties have zero psychiatrists—a geographic coverage gap that affects Spring Health's ability to provide medication management services in rural and underserved areas, which may be a material concern for large employers with dispersed workforces (Target, Delta, Wawa). | 高 | SR017, SR016 |
| CR019 | BenefitsPRO (2025) reports that employer benefits budget scrutiny in 2024–2025 has led CFOs to challenge renewal pricing for all supplemental mental health benefit platforms, including Spring Health—creating renewal risk for contracts where ROI has not been demonstrated within the Year 1 cost-neutrality commitment. | 中 | SR018, SR011 |
| CR020 | Spring Health has no publicly identified active litigation, regulatory enforcement actions, or provider disputes as of the run date. The absence of disclosed legal proceedings supports but does not confirm a clean legal record. | 中 | SR013, SR011 |
| CR021 | Spring Health's 50-state telehealth network requires compliance with state-level prescribing laws, telehealth parity statutes, and clinical licensing requirements that vary by state. The complexity of multi-state clinical licensure for 10,000+ providers is an ongoing operational risk that scales with network growth. | 中 | SR001, SR011 |
| CR022 | Fierce Healthcare (2025) notes that digital behavioral health companies face dual regulatory pressure in 2025: increased MHPAEA enforcement targeting utilization management practices, and FTC data privacy oversight of mental health data sharing—creating a compliance investment requirement that smaller competitors cannot easily absorb and that could favor Spring Health's institutional compliance infrastructure. | 中 | SR011, SR014 |
| CR023 | Becker's Hospital Review (2025) identifies AI clinical decision support liability as the most rapidly evolving legal risk for digital health companies in 2025—noting that court precedents for AI-based clinical recommendations are still forming and that standard product liability disclaimers may not protect companies from professional negligence claims when AI is used in clinical settings. | 中 | SR028, SR021 |
| CR024 | Spring Health's VERA-MH framework, AI Ethics Council, and URAC accreditation collectively form the company's current AI governance and risk mitigation infrastructure—a more proactive compliance posture than most digital health peers, but one that addresses known risks (chatbot safety, provider quality) while leaving novel risks (Guide AI proactive model, employer data analytics) less clearly addressed. | 中 | SR022, SR009, SR010 |
| CR025 | Spring Health's HHS OCR Breach Notification obligations at 20M covered lives scale mean that any breach affecting more than 500 individuals in a single state triggers public reporting to HHS and media notification. A breach at full network scale would trigger one of the largest digital health HIPAA breach notifications in history. | 高 | SR026, SR002 |
| CR026 | Modern Healthcare (2025) analysis identifies Spring Health's competitive moat as real but narrowing: Lyra's clinical expansion and Optum's payer-integrated model are both closing the gap on Spring Health's lead in outcomes evidence and clinical depth—and the competitive advantage could erode over 12–24 months without continued product investment. | 中 | SR023, SR013 |
| CR027 | The risk that a hyperscaler employer (Microsoft, Google, Amazon) builds or acquires an internal mental health benefit solution is low in the near term—these companies have historically outsourced HR technology—but cannot be dismissed for a 5-year horizon given the size of their health benefits budgets and prior investments in health technology. | 低 | SR012, SR023 |
| CR028 | CMS (2024) mental health parity enforcement data shows that health plans are increasingly required to produce NQTL analyses for behavioral health benefits—a trend that creates new documentation requirements for Spring Health's health plan channel partners and could affect the Knox-Keene model's commercial viability if plan sponsors find NQTL compliance burdensome. | 中 | SR014, SR001 |
| CR029 | JD Supra (2024) analysis confirms that the intersection of 42 CFR Part 2 and employer analytics reporting is a high-risk area: many digital health employers routinely share aggregate utilization data with employer HR analytics dashboards, but Part 2 prohibits sharing SUD-identifiable data without specific, written consent—a requirement that may conflict with standard employer reporting models. | 中 | SR027, SR008 |
| CR030 | Healthcare Finance News (2025) analysis of Spring Health's financial sustainability identifies the transition from a high-capital-raise, loss-making growth model to a capital-efficient, near-profitability model as the critical financial risk for the next 18–24 months—noting that the absence of a disclosed Series F or IPO roadmap creates uncertainty about the company's long-term capital strategy. | 中 | SR029, SR024 |
| CR031 | Spring Health's URAC crisis program accreditation provides documented evidence of clinical crisis protocols—mitigating the most severe clinical risk (member suicide or acute psychiatric crisis during platform use) and providing a governance standard against which Guide AI's crisis escalation can be evaluated. | 高 | SR010, SR009 |
| CR032 | SAMHSA (2024) projects the behavioral health workforce shortage at 250,000+ unfilled positions by 2030—a systemic supply constraint that affects Spring Health's ability to offer rapid access to psychiatrists, psychologists, and licensed therapists. Spring Health's telehealth model mitigates some geographic constraints but cannot create provider capacity from a limited workforce pool. | 高 | SR016, SR017 |
| CR033 | Spring Health's compliance posture (URAC, Knox-Keene, VERA-MH, AI Ethics Council) is notably more proactive than most digital health peers—suggesting deliberate regulatory investment rather than reactive compliance—which may provide a competitive moat against smaller competitors who cannot absorb the compliance cost, while also reducing enforcement risk for Spring Health itself. | 中 | SR010, SR006, SR022 |
| CR034 | HHS OCR enforcement data (HIPAA Journal 2024 compilation) shows that the average HIPAA settlement amount for healthcare breaches in 2023–2024 was $0.5M–$1M for incidents involving 1,000–100,000 individuals, with potential class action litigation adding multiples of that for large-scale breaches—creating a material tail risk for Spring Health's 20M-person data estate. | 中 | SR007, SR026 |
| CR035 | Spring Health does not publicly disclose the terms of its ROI guarantee compensation mechanism—i.e., whether failing to deliver 3× ROI by Year 3 results in cash payment, service credits, or contract extension for the employer. Without this disclosure, the financial liability exposure from guarantee underperformance cannot be quantified. | 高 | SR015, SR029 |
| CR036 | The FTC Cerebral, Inc. enforcement action (2023, estimated $7M settlement) against a digital mental health company for misleading subscription cancellation practices and controlled substance prescription issues created a second enforcement precedent reinforcing that digital mental health platforms face active FTC oversight beyond BetterHelp. | 中 | SR003, SR021 |
| CR037 | Spring Health's international language support (100+) and multinational employer clients (Microsoft) create additional regulatory jurisdictions: GDPR (EU), PIPEDA (Canada), and national mental health data laws in regions where Spring Health operates. International data privacy compliance requirements are not publicly disclosed for Spring Health. | 低 | SR011, SR013 |
| CR038 | Spring Health's Specialty Care expansion into eating disorders—a high-acuity, high-mortality condition—significantly increases clinical liability exposure relative to standard EAP services. Eating disorder treatment involves complex step-of-care decisions, medical monitoring, and potential hospitalization triggers that require robust clinical protocols and professional liability coverage. | 中 | SR028, SR013 |
| CR039 | Spring Health's growth from 1M to 20M covered lives in five years, without any disclosed quality degradation signal, is the strongest evidence that the company's clinical model scales—but the absence of adverse incident disclosure does not confirm absence of adverse incidents; it only confirms that none have become public. | 中 | SR013, SR016 |
| CR040 | The combination of MHPAEA 2024 final rule compliance requirements, FTC data privacy enforcement post-BetterHelp, California DMHC Knox-Keene oversight, and HIPAA/HITECH obligations creates a multi-layered regulatory burden that is material but manageable for a company of Spring Health's scale and compliance investment—and may serve as a barrier to entry for smaller competitors. | 中 | SR001, SR003, SR005, SR002 |
| CV001 | Spring Health raised $100M at a $3.3 billion pre-money valuation in its Series E round in April 2024, led by Generation Investment Management. | 高 | SV001, SV002, SV007 |
| CV002 | At the $3.3B valuation and an estimated ARR range of $130–300M, Spring Health's implied ARR multiple spans approximately 11–25×, depending on the revenue estimate used. | 中 | SV002, SV021, SV006 |
| CV003 | To justify a $3.3B valuation at market-normalized digital health SaaS multiples of 5–8×, Spring Health would need ARR of $412M–$660M — well above analyst estimates for 2024 — implying the current valuation prices in substantial future growth. | 中 | SV006, SV015, SV019 |
| CV004 | Spring Health has raised approximately $488M in total across Series A ($22M, 2020), B ($76M, 2021), C ($190M at $2B, 2022), and E ($100M at $3.3B, 2024); no Series D was announced publicly. | 高 | SV021, SV010, SV001 |
| CV005 | Spring Health's CEO April Koh and investor Generation Investment Management have both signaled eventual IPO optionality in 2025–2026 media coverage, though no formal IPO timeline has been announced. | 中 | SV017, SV023, SV008 |
| CV006 | The JAMA Psychiatry 2025 peer-reviewed RCT showing 1.9× ROI and 50% lower hospitalization rates for Spring Health members vs. standard EAP is a clinical outcomes differentiator that most competitors lack. | 高 | SV015, SV027 |
| CV007 | The MHPAEA 2024 Final Rule enforcement cycle creates new employer demand for mental health benefits programs with documented comparative NQTL analyses, potentially benefiting Spring Health as MHPAEA compliance becomes a selection criterion. | 中 | SV018, SV024 |
| CV008 | Spring Health's guaranteed ROI structure (cost-neutral Year 1, 1.5× Year 2, 3× Year 3) reduces employer churn risk but creates unquantified contingent liability if guarantee payouts are triggered for underperforming cohorts. | 中 | SV027, SV025 |
| CV009 | The Alma acquisition (completed 2025) extends Spring Health from employer-only into health plan and consumer channels, but introduces integration risk and a potential blended ARR multiple dilution given Alma's consumer marketplace model. | 中 | SV025, SV011 |
| CV010 | In a bull scenario, Spring Health reaches $500M+ ARR by 2027 through health plan channel expansion, international growth, and Specialty Care, implying a $7.5–10B valuation at 15–20× ARR — a 2.3–3× return from the $3.3B Series E entry. | 低 | SV006, SV018 |
| CV011 | In a base scenario, Spring Health achieves $200–300M ARR by 2027 with 30–40% CAGR in the employer channel, implying a $2.4–4.5B valuation at 12–15× ARR — approximately flat to modestly positive returns from $3.3B. | 中 | SV006, SV015, SV021 |
| CV012 | In a bear scenario, employer churn accelerates, ARR growth falls below 20%, and public comp re-rating compresses multiples to 4–6×, implying a valuation of $520M–$780M — a potential 75–85% impairment from $3.3B. | 低 | SV006, SV016 |
| CV013 | The probability-weighted expected return from $3.3B entry is approximately 1.2–1.5× over a 4–7 year horizon in the base case, with bull case providing 2.5–3× and bear case −75% to −85%. | 低 | SV006, SV015 |
| CV014 | Strategic M&A exits remain plausible for Spring Health, particularly from a large insurer (Cigna, Aetna, UnitedHealth/Optum) seeking employer mental health capabilities or a PBM seeking benefit platform expansion. | 中 | SV017, SV016 |
| CV015 | Accolade (ACCD) reported approximately $360M ARR for fiscal 2025; its market cap was approximately $500M as of Q4 2024, implying a 1.4× ARR multiple — a fraction of Spring Health's 11–25× implied multiple. | 高 | SV004, SV019 |
| CV016 | Talkspace (TALK) reported approximately $110M ARR for 2024; its market cap was approximately $320M as of Q1 2025, implying a 2.9× ARR multiple. | 高 | SV005, SV020 |
| CV017 | Teladoc Health (TDOC) reported $2.6B revenue for 2023 with a market cap of approximately $3.5B as of Q4 2024, implying a 1.3× revenue multiple — down from peak 2021 multiples above 30× following $13.4B cumulative Livongo impairment charges. | 高 | SV013, SV019 |
| CV018 | Lyra Health's last disclosed valuation was $4.8B in its 2022 Series F round; no new financing has been disclosed as of May 2026, suggesting the $4.8B figure is likely stale and probably marked down on fund NAVs given market conditions. | 中 | SV014, SV016 |
| CV019 | Modern Health's last disclosed valuation was $1.17B in 2021; no new financing has been disclosed as of May 2026, making it likely marked down significantly from 2021 peak given digital health sector re-rating. | 中 | SV014 |
| CV020 | Headspace and Calm merged in 2021 at an estimated $3B combined valuation; the merged entity has not disclosed new financing as of 2025, suggesting their consumer-dominant model has faced greater headwinds than employer B2B models. | 中 | SV014, SV016 |
| CV021 | If Spring Health's ARR is confirmed below $100M, the $3.3B valuation implies a >33× multiple that is not justifiable by any comparable digital health SaaS growth trajectory, constituting a thesis-break. | 中 | SV015, SV006 |
| CV022 | Sustained gross employer logo churn above 15% annually would signal structural product-market fit erosion and likely trigger NRR below 90%, constituting a thesis-break. | 中 | SV027, SV015 |
| CV023 | A material FTC enforcement action against Spring Health for Guide AI data sharing — following the 2023 BetterHelp consent order precedent — would pause AI product development, freeze enterprise sales, and likely trigger class action liability. | 中 | SV009, SV016 |
| CV024 | A down-round at 30%+ below $3.3B (i.e., below $2.3B) would signal a fundamental miss on growth or profitability targets relative to Series E investor expectations, constituting a conditional thesis-break. | 中 | SV008, SV015 |
| CV025 | A Guide AI-related clinical adverse event with FDA enforcement action or state medical board intervention would be a thesis-break trigger, requiring AI product suspension and creating unquantified liability. | 中 | SV017, SV009 |
| CV026 | Spring Health's single highest-priority diligence ask is ARR and net revenue retention by employer cohort vintage (2020–2024), as the entire valuation thesis depends on this undisclosed data. | 高 | SV002, SV008, SV027 |
| CV027 | MHPAEA NQTL comparative analysis for Spring Health's utilization management protocols is a critical regulatory diligence ask because employer clients bear primary MHPAEA compliance obligation. | 高 | SV018, SV024 |
| CV028 | Guide AI clinical liability legal opinion and insurance coverage is a material diligence ask because the guaranteed ROI model and proactive AI outreach increase clinical liability exposure vs. standard EAP. | 高 | SV017, SV009 |
| CV029 | Channel economics — employer PMPM, CAC payback, and account-level NRR by 12/24/36-month cohort — are critical because health plan economics likely differ materially from employer economics and affect the growth thesis. | 高 | SV024, SV018 |
| CV030 | Spring Health has raised approximately $488M in total capital; if ARR is $130–300M, capital efficiency is approximately 0.27–0.61× ARR per dollar raised, below the top-decile SaaS benchmark of 1× or better at this funding level. | 中 | SV021, SV015 |
| CV031 | Digital health SaaS NTM revenue multiples compressed from 30–80× in 2021 to 2–5× in 2024–2025 for public companies, reflecting rising rates, profitability demands, and sector-specific execution disappointments. | 高 | SV013, SV006, SV016 |
| CV032 | Spring Health's $3.3B valuation (2024) at an estimated 11–25× ARR represents a significant compression from the 30–80× multiples that prevailed in the 2021 peak for digital health, yet maintains a 4–8× premium over distressed public comps. | 中 | SV007, SV008, SV015 |
| CV033 | CB Insights and PitchBook both confirm Spring Health's unicorn status at $3.3B as of April 2024, with total funding tracked at $488M+. | 高 | SV012, SV014 |
| CV034 | Teladoc's 2023 10-K shows the behavioral health segment contributing approximately $400M of the $2.6B total revenue, a data point used as a rough sanity check on employer mental health platform ARR benchmarks. | 中 | SV013 |
| CV035 | Teladoc's $13.4B cumulative Livongo impairment (2022–2023) and Cerebral's operational restructuring (2022–2023) are digital health precedents for rapid down-round or write-down scenarios that investors must consider for Spring Health. | 高 | SV013, SV016 |
| CV036 | BetterHelp (Teladoc subsidiary) experienced a 30%+ revenue decline in 2023 due to consumer spending softness, while employer-facing mental health platforms like Spring Health showed more resilient retention — a sector divergence favorable to Spring Health. | 中 | SV013, SV006 |
| CV037 | Accolade's 10-K and investor relations materials confirm ~$360M ARR guidance for fiscal 2025 and disclose employer navigation segment metrics, including gross retention rates of approximately 90%+ — a useful benchmark for Spring Health diligence. | 高 | SV004, SV019 |
| CV038 | Generation Investment Management, the Series E lead, focuses on long-duration impact investments with 5–10 year holding periods, suggesting Spring Health's IPO timeline is not imminent and secondary liquidity may be limited. | 中 | SV023, SV017 |
| CV039 | Spring Health's total capital raised of $488M combined with estimated ARR of $130–300M implies roughly $1.6–3.8 raised per dollar of ARR, which is above the efficient threshold but not outlier for enterprise healthcare SaaS requiring long sales cycles. | 低 | SV021, SV015 |
| CV040 | The employer mental health benefits market is estimated at $10B+ annually in the U.S., with the global mental health services market projected to reach $538B by 2030 at a 9.9% CAGR, providing a structural growth backdrop supporting premium valuations. | 中 | SV030, SV018 |